Webinar Recording
Back to course
Video Transcription
Hello, and welcome to the webinar entitled Addressing Drug Impaired Driving, an Evidence-Based Approach.
I'm Dr. Angela Michelide, Vice President of Programs and Education at the American College of Preventive Medicine.
The American College of Preventive Medicine is a professional medical society of more than 2,000 physicians dedicated to improving the health and quality of life of individuals,
families, communities, and populations through disease prevention and health promotion. Our members are licensed medical doctors or doctors of osteopathy who possess expertise
in a broad range of healthcare skills, including biostatistics, epidemiology, management of healthcare organizations, research, and the practice of prevention in clinical settings.
Our physicians work in a variety of settings, including hospitals, government at the local, state, and national levels, the military, laboratories, businesses, and academia.
I have just a few housekeeping items to share with you today. The audience has been placed in listen-only mode, and we will be posting a recording of
this webinar on the ACPM.org website in just a few days in the event that you'd like to share it with friends and colleagues.
We encourage you to type questions throughout the presentation in the Q&A box, and we want to know what you think and how we can do better.
So please fill out the survey that you will receive after the webinar so that we can improve our offerings. I'm delighted to introduce our two speakers today.
Video Summary
In this webinar, the speakers discussed the impact of cannabis use on impaired driving. They presented research findings on the association between cannabis legalization and fatal collisions in the United States, finding a 15% increase in fatal collisions following legalization. They also highlighted the potential risks and effects of cannabis use on psychomotor skills and cognitive functions necessary for driving. The speakers discussed prevention strategies and suggested possible roles for healthcare professionals in promoting safer cannabis use. They mentioned the importance of public awareness of the risks of drug-impaired driving and the need for effective educational campaigns. They also mentioned the use of warning labels on cannabis packaging, roadside drug testing, and media campaigns as potential deterrents. The speakers emphasized the need for more research on the long-term effects of cannabis use on driving and the evaluation of prevention interventions. They also discussed the challenges in collecting and reporting data on drug-impaired driving and suggested future research on improving reporting systems and evaluating interventions for reducing drug-impaired driving.
cannabis use
impaired driving
cannabis legalization
fatal collisions
prevention strategies
public awareness
warning labels
roadside drug testing
long-term effects

American College of Preventive Medicine
1200 First Street NE, Suite 315 - Washington, DC 20002
202-466-2044  ·  info@acpm.org

Powered By